The FY2025 (Dec) proxy of Lineage Cell Therapeutics names 21 peer companies for pay. Among Lineage Cell Therapeutics and these peers, CEO pay was 9th highest of 11 and total shareholder return was 5th highest of 11.
9th highest of 11in Lineage Cell Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:
$1.4M$8.3M
5th highest of 11in Lineage Cell Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:
$7$748
Pay peer group, FY2025 (Dec) proxy
| MeiraGTx Holdings | ||
| Anaptysbio | ||
| Cartesian Therapeutics | ||
| Capricor Therapeutics | ||
| aTYR Pharma | ||
| Nkarta | ||
| Verastem | ||
| Fate Therapeutics | ||
| 4D Molecular Therapeutics | ||
| Agenus | ||
| Adverum Biotechnologies, Inc. | Not disclosed | Not disclosed |
| Allogene Therapeutics | Not disclosed | Not disclosed |
| BioAtla, Inc. | Not disclosed | Not disclosed |
| Celularity Inc | Not disclosed | Not disclosed |
| Century Therapeutics | Not disclosed | Not disclosed |
| Chimerix Inc | Not disclosed | Not disclosed |
| Gritstone bio, Inc. | Not disclosed | Not disclosed |
| Kyverna Therapeutics Inc | Not disclosed | Not disclosed |
| REGENEXBIO Inc. | Not disclosed | Not disclosed |
| Sana Biotechnology | Not disclosed | Not disclosed |
| Vor Biopharma | Not disclosed | Not disclosed |
'%20fill='%23fff'/%3e%3cpath%20id='fullLogo-2'%20d='M18.156,40.577.011,29.356l0-18.125L18.147,0'%20transform='translate(-0.004%20-0.001)'%20fill='%23fff'/%3e%3cpath%20id='fullLogo-3'%20d='M35.133,14.327H26.354l4.389-7.163L35.127,0l4.395,7.164,4.389,7.163Z'%20transform='translate(-16.985)'%20fill='%2351c0d4'/%3e%3cpath%20id='fullLogo-4'%20d='M51.052,93.782l0-8.211,18.178-3.019Z'%20transform='translate(-32.9%20-53.206)'%20fill='%2300b3cd'/%3e%3cpath%20id='fullLogo-5'%20d='M69.213,11.223l-9.4,3.1L51.035,0Z'%20transform='translate(-32.892%20-0.001)'%20fill='%2300b3cd'/%3e%3cpath%20id='fullLogo-6'%20d='M.01,11.23l9.387,3.1L18.148,0Z'%20transform='translate(-0.006%20-0.001)'%20fill='%2300b3cd'/%3e%3cpath%20id='fullLogo-7'%20d='M75.741,34.672l9.4-3.1,0,18.125Z'%20transform='translate(-48.815%20-20.345)'%20fill='%233fbcd2'/%3e%3cpath%20id='fullLogo-8'%20d='M9.406,34.672l-9.4-3.1,0,18.125Z'%20transform='translate(-0.004%20-20.345)'%20fill='%233fbcd2'/%3e%3cpath%20id='fullLogo-9'%20d='M18.15,93.786l.016-8.209L0,82.56Z'%20transform='translate(0%20-53.21)'%20fill='%233fbcd2'/%3e%3cpath%20id='fullLogo-10'%20d='M59.826,40.3,51.047,58.34l18.178-3.019Z'%20transform='translate(-32.9%20-25.974)'%20fill='%2351c0d4'/%3e%3cpath%20id='fullLogo-11'%20d='M9.393,40.3l8.773,18.041L0,55.321Z'%20transform='translate(0%20-25.971)'%20fill='%2351c0d4'/%3e%3cpath%20id='fullLogo-12'%20d='M35.174,40.3H26.418l4.367,9.019,4.4,9.027,4.373-9.027,4.389-9.02Z'%20transform='translate(-17.026%20-25.974)'%20fill='%238fd4e2'/%3e%3c/svg%3e)
21 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.